Podcast
David Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood Fund
S2 Episode 1 of BioByteas by Windsor Bux welcomes David Donabedian, PhD – Executive Partner
David Donabedian, a senior executive in the biotech industry, shares his journey and insights on building and scaling biotech companies. He emphasizes the importance of passion, persistence, and trusting your gut when making decisions. He also highlights the significance of building a culture of innovation and collaboration within organizations. He advises emerging biotech entrepreneurs to focus on great science, build strong teams, and be persistent in attracting investment. He encourages them to lean on advisors and mentors for support and to always keep the goal of making a difference for patients in mind.
Takeaways
- Passion and excitement are essential in the biotech industry, as they drive the desire to make a difference for patients.
- Persistence and perseverance are key qualities for success in the industry, as setbacks and challenges are common.
- Building a culture of innovation and collaboration is crucial for the growth and success of biotech companies.
- Emerging biotech entrepreneurs should focus on great science, build strong teams, and be persistent in attracting investment.
- Seeking advice and support from mentors and advisors can provide valuable guidance and help navigate challenges.
- Always keep the goal of making a difference for patients at the forefront of decision-making and company building.
You can also listen to this podcast on Spotify:
Welcome to BioBytes – Windsor Bux, where we bring you exclusive interviews with the movers and shakers of the biotech and pharmaceutical industry. Join us as we delve into the experiences and valuable insights of leading executives, exploring how they’re shaping the future and making a difference. Get ready for compelling conversations that will expand your knowledge and inspire your own journey in this exciting field!
- Shehnaaz Suliman, M.D, CEO at ReCode Therapeutics
- Sandy Milligan, MD JD, C-Suite Executive & Board Member
- Alex Oshmyansky, MD, PhD, CEO / Co-Founder
- Derek Adams, CEO & President
- Jason Cole – CEO & Chair of the Board, SalioGen
- David Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood Fund
- Stephanie Oestreich, PhD, MPA Managing Director at Myeloma Investment Fund
- Ronan O’Hagan, Chief Executive Officer
- Alison Schecter, MD, CMO/CEO
- Joe Foster – Reebok, Founder